Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate advances Medicaid preferred-drug changes aimed at saving on pharmaceuticals
Summary
Senate passed SB137 to expand the Medicaid preferred drug list (PDL) to negotiate better prices and redirect savings to mental-health providers and emergency dental services; proponents said it will reduce drug spending, opponents warned about impacts on mental-health patients.
The Utah Senate on Feb. 25 approved first substitute Senate Bill 137, which expands the state Medicaid Preferred Drug List (PDL) to include additional medications, with sponsor statements indicating projected savings and safeguards for patients.
A presenter noted that Medicaid spends roughly $150–175 million a year on drugs for program clients and that the PDL mechanism has produced greater savings than initially estimated. "A…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
